HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 10/09/2012 -- Beazer Homes USA (NYSE: BZH : 3.58, -0.055), with an "Underperform" rating, continue to witness the worst gross margins in the sector with a new vision of "No Community Left Behind" and the highest leveraged balance sheet (10.4 percent of fiscal 2012 Revenues are eaten up by Interest Incurred on debt) in the space, the analyst wrote. "Our $2.25/share target price represents a 0.9x multiple of our forecasted year end fiscal 2013 adjusted price/book," the analyst said.New York, NY- Beazer Homes USA, (NYSE:BZH) is very active today and traded between $3.46 - 4.054 with total traded volume of 2705885 shares. At a current price of 3.55, BZH is -0.07 - -1.93% from the previous close of $3.62. Moreover, At Current Market Price, BZH is in the distance of +6.08% from its 50-day Moving Average price of $3.3466 and +20.99% from its 200-day Moving Average price of $2.9342.
How Should Investors React To BZH Now? Find Out Here
Sarepta Therapeutics Inc. (NASDAQ:SRPT), formerly AVI BioPharma, Inc., is a biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of both rare and infectious diseases. The Company is primarily focused on rapidly advancing the development of its disease-modifying Duchenne muscular dystrophy drug candidates with the intent to realize the product opportunities of such candidates and provide clinical benefits. It is also focused on developing therapeutics for the treatment of infectious diseases.Sarepta Therapeutics (SRPT). Only a few weeks ago, the stock was trading in the $3 to $4 range. On 10/3/12, the company announced that it received positive phase IIb clinical data for its Duchenne muscular dystrophy drug eteplirsen.Sarepta Therapeutics Inc (SRPT) is currently trading at $32.85. Its 52 week range is between $2.6 and $45.
How Should Investors Trade SRPT Now? Check Here
Nokia Corporation (NOK) provides telecommunications infrastructure hardware, software, and services worldwide. The company offers smart phones and smart devices; and feature phones, and related services and applications. It provides feature phones and smart phones under the Nokia brand; and mobile devices under the Vertu name. Nokia has just inked a deal with AT&T for exclusive rights to sell their new smartphone with the windows 8 platform in hopes to boost sales.Nokia Corporation (NYSE:NOK) is up 3.36% in pre market trading at $2.77. NOK has traded over 200 thousand shares already this morning and trades 57.1 million shares a day on average. T-Mobile said today it will carry Nokia’s new Lumia 810 which is powered by Windows 8. This comes a week after AT&T said it would carry the Lumia 920 and 820. The company has a market cap of 9.95 billion.
Can this be the boost that NOK needs? Find out more here
VeriFone Systems, Inc. (PAY), formerly VeriFone Holdings, Inc., is a holding company for VeriFone, Inc. The Company is engaged in the secure electronic payment solutions. It provides solutions, and services for the financial, retail, hospitality, petroleum, transportation, government, and healthcare vertical markets.PAY recently entered into an agreement with Valero Retail Holdings, Inc. to deploy VeriFone PAYMEDIA for Secure PumpPAY solutions in Austin, Texas.VeriFone Systems, Inc. (NYSE:PAY) is down 7.59% today at $28.50. PAY is trading 4.3 million shares this morning, above its average volume of 3.2 million shares. PAY shares are dipping today on reports that Square is close to a deal to equip 1,000 New York City cabs with its credit card readers over the next year. The company has a market cap of 3.10 billion.
Can PAY Recover? Don’t Forget To Sign Up For Free Trend Analysis on PAY Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)